Cargando…
Photoactivatable nanoagonists chemically programmed for pharmacokinetic tuning and in situ cancer vaccination
Immunotherapy holds great promise for the treatment of aggressive and metastatic cancers; however, currently available immunotherapeutics, such as immune checkpoint blockade, benefit only a small subset of patients. A photoactivatable toll-like receptor 7/8 (TLR7/8) nanoagonist (PNA) system that imp...
Autores principales: | Wan, Jianqin, Ren, Lulu, Li, Xiaoyan, He, Shasha, Fu, Yang, Xu, Peirong, Meng, Fanchao, Xian, Shiyun, Pu, Kanyi, Wang, Hangxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974508/ https://www.ncbi.nlm.nih.gov/pubmed/36787350 http://dx.doi.org/10.1073/pnas.2210385120 |
Ejemplares similares
-
Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer
por: Jiang, Yuyan, et al.
Publicado: (2021) -
Ultrasmall organosilica nanoparticles with strong solid-state fluorescence for multifunctional applications
por: Wan, Jianqin, et al.
Publicado: (2022) -
Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy
por: Zhan, Meixiao, et al.
Publicado: (2022) -
Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity
por: Chen, Xiaona, et al.
Publicado: (2023) -
A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses
por: Wang, Xuan, et al.
Publicado: (2022)